SG Americas Securities’s Solid Biosciences SLDB Stock Holding History

SG Americas Securities’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$161K	Buy	+16,136	New	+$122K	﹤0.01%	2890
2026 Q1	–	Sell	-20,876	Closed	-$118K	–	3654
2025 Q4	$118K	Buy	+20,876	New	+$113K	﹤0.01%	3161
2025 Q3	–	Sell	-13,086	Closed	-$64K	–	3543
2025 Q2	$64K	Buy	+13,086	New	+$46.3K	﹤0.01%	2730
2022 Q1	–	Sell	-1,125	Closed	-$30K	–	3385
2021 Q4	$30K	Sell	1,125 -1,254	-53%	-$38.3K	﹤0.01%	3240
2021 Q3	$85K	Buy	+2,379	New	+$101K	﹤0.01%	3688
2021 Q1	–	Sell	-1,010	Closed	-$115K	–	3526
2020 Q4	$115K	Buy	+1,010	New	+$63.9K	﹤0.01%	2961
2020 Q3	–	Sell	-917	Closed	-$40K	–	3373
2020 Q2	$40K	Buy	+917	New	+$38.1K	﹤0.01%	3568
2018 Q4	–	Sell	-321	Closed	-$227K	–	3291
2018 Q3	$227K	Buy	+321	New	+$202K	﹤0.01%	2501

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SG Americas Securities's SLDB Position: Q2 2026 in Review

SG Americas Securities opened a new position in Solid Biosciences (SLDB) in Q2 2026: 16,136 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #2890 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in SLDB as recently as Q4 2025.

SG Americas Securities first reported a position in SLDB in Q3 2018 and has held it in 8 quarters since. The position peaked at $227K in Q3 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

SG Americas Securities held 16,136 shares of Solid Biosciences worth $161K as of Q2 2026.
Solid Biosciences was a new SG Americas Securities position in Q2 2026.
Solid Biosciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2890 holding.
SG Americas Securities first reported a position in Solid Biosciences in Q3 2018 and has held it in 8 quarters since.
SG Americas Securities's Solid Biosciences position peaked at $227K in Q3 2018.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.